Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tursz

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Research in Immunology|May 1, 1992
CD23 and the Epstein-Barr virusG Rousselet, T Tursz
Pathologie-Biologie|June 1, 1988
[Cancer: what choices for research?]M Boiron, T Tursz
Bulletin De L'Academie Nationale De Medecine|November 1, 1986
[Human cancers of viral origin. Burkitt's disease as a model of human carcinogenesis]M Tubiana, T Tursz
Advances in Cancer Research|January 1, 1991
ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBVJ Yodoi, T Tursz
Annales De Pediatrie|April 1, 1987
[Burkitt's disease]M Tubiana, T Tursz
Bulletin Du Cancer|January 1, 1988
[Contribution of immunology and molecular biology]M Lipinski, T Tursz
Pathologie-Biologie|December 1, 1971
[The origin of antibody diversity]A Bernard, T Tursz
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Monoclonal antibody against a Burkitt lymphoma-associated antigenJ Wiels, M Fellous, T Tursz
IARC Scientific Publications|January 1, 1985
38.13: a monoclonal antibody directed against a Burkitt's lymphoma-associated antigen and its use as carrier for toxinsJ Wiels, A Balaña, T Tursz
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Dendritic cell-based immunotherapy of cancerL Zitvogel, E Angevin, T Tursz
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Research in Immunology|May 1, 1992
CD23 and the Epstein-Barr virusG Rousselet, T Tursz
Pathologie-Biologie|June 1, 1988
[Cancer: what choices for research?]M Boiron, T Tursz
Bulletin De L'Academie Nationale De Medecine|November 1, 1986
[Human cancers of viral origin. Burkitt's disease as a model of human carcinogenesis]M Tubiana, T Tursz
Advances in Cancer Research|January 1, 1991
ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBVJ Yodoi, T Tursz
Annales De Pediatrie|April 1, 1987
[Burkitt's disease]M Tubiana, T Tursz
Bulletin Du Cancer|January 1, 1988
[Contribution of immunology and molecular biology]M Lipinski, T Tursz
Pathologie-Biologie|December 1, 1971
[The origin of antibody diversity]A Bernard, T Tursz
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Monoclonal antibody against a Burkitt lymphoma-associated antigenJ Wiels, M Fellous, T Tursz
IARC Scientific Publications|January 1, 1985
38.13: a monoclonal antibody directed against a Burkitt's lymphoma-associated antigen and its use as carrier for toxinsJ Wiels, A Balaña, T Tursz
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Dendritic cell-based immunotherapy of cancerL Zitvogel, E Angevin, T Tursz
Pageof 24